Thiosuccinyl peptides as Sirt5-specific inhibitors

Area of Science:

• Biochemistry
• Enzymology
• Drug Discovery

Background:

• Sirtuins (nicotinamide adenine dinucleotide-dependent deacetylases) regulate critical biological processes like aging, transcription, and metabolism.
• Human sirtuins (Sirt1-7) are implicated in various diseases, making them key targets for therapeutic intervention.
• Developing selective small molecules for individual sirtuins is crucial for drug development and biological studies.

Purpose of the Study:

• To identify and characterize novel inhibitors targeting specific human sirtuins.
• To leverage unique enzymatic properties of sirtuins for selective inhibitor design.
• To develop potent and selective inhibitors for Sirt5.

Main Methods:

• Enzyme inhibition assays were performed to evaluate the potency and selectivity of candidate inhibitors.
• Inhibitor design was guided by the unique substrate preference of Sirt5 for malonyl and succinyl groups.
• Comparative analysis of acyl group hydrolysis across different human sirtuin family members.

Main Results:

• Thiosuccinyl peptides were identified as potent and selective inhibitors of Sirt5.
• Sirt5 exhibits a unique preference for hydrolyzing malonyl and succinyl groups over acetyl groups.
• This acyl group preference is unique among the seven human sirtuins.

Conclusions:

• Thiosuccinyl peptides represent a promising class of Sirt5 inhibitors.
• The distinct acyl group preferences of sirtuins can be exploited to develop highly selective inhibitors.
• This approach facilitates targeted drug development and fundamental research into sirtuin biology.